IMC-002(Immuneoncia)
N/A
Report date: 2025/10/24 20:00:54
Base Information
Drug NameIMC-002(Immuneoncia)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[7]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesImmuneoncia Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesYiming Kell Biomedical Technology (Shanghai) Co Ltd3d Medicines IncSuzhou Immunofoco Biotechnology Co Ltd +[5]
Inactive CompaniesN/A
Active Indications +[6]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A